1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Germany Pharmaceuticals and Healthcare Report Q3 2016

Germany Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 102 pages

Includes 3 FREE quarterly updates

BMI View: Germany's pharmaceutical and healthcare markets will continue to expand over the next tenyears, translating into renewed commercial opportunities for drugmakers operating in the country. Whilepatented medicines will continue to account for the largest share of the pharmaceutical market, genericmedicines will outpace the overall market growth rate, gaining market share. In fact, we expect to seegovernment cost control measures and market structure to support the gradual commoditisation of thegeneric drug market, which will put downward pressure on prices, despite growing volumes.

Headline Expenditure Projections

- Pharmaceuticals: EUR46.50bn (USD51.15bn) in 2015 to EUR47.10bn (USD50.40bn) in 2016; +1.3%in local currency terms and -1.5% in US dollar terms. Forecast in line with last quarter.

- Healthcare: EUR339.30bn (USD373.23bn) in 2015 to EUR349.82bn (USD374.30bn) in 2016; +3.1% inlocal currency terms and +0.3% in US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

Germany Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Germany 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Germany 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Germany 2012-2020) 19
Table: Retail Pharmaceutical Expenditure, 2003-2010 (EURbn) 19
Table: Retail Pharmaceutical Expenditure, 2003-2010 (Packages, ms) 20
Table: Retail Pharmaceutical Expenditure, 2003-2010 (Average Price per Pack, EUR) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Germany 2012-2020) 23
Generic Medicine Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Germany 2012-2020) 26
OTC Medicine Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Germany 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Germany 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Germany 2014-2020) 31
Pharmaceuticals Risk/Reward Index 32
Western Europe Risk/Reward Index 32
Germany Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Intellectual Property Regime 41
Pricing Regime 42
Reimbursement Regime 46
Market Overview 48
Healthcare Sector 49
Table: Healthcare Resources (Germany 2010-2015) 51
Table: Healthcare Personnel (Germany 2010-2015) 52
Table: Healthcare Activity (Germany 2010-2015) 52
Research and Development 52
Clinical Trials 59
Epidemiology 60
Competitive Landscape 62
Research-Based Industry 62
Table: Multinational Market Activity 64
Pharmaceutical Distribution 65
Pharmaceutical Retail Sector 65
Company Profile 67
Bayer Health Care 67
Boehringer Ingelheim 72
GlaxoSmithKline (GSK) 77
Merck KGaA 80
Pfizer 84
STADA Arzneimittel 87
Demographic Forecast 91
Demographic Outlook 91
Table: Population Headline Indicators (Germany 1990-2025) 92
Table: Key Population Ratios (Germany 1990-2025) 92
Table: Urban/Rural Population and Life Expectancy (Germany 1990-2025) 93
Table: Population By Age Group (Germany 1990-2025) 93
Table: Population By Age Group % (Germany 1990-2025) 94
Glossary 96
Methodology 98
Pharmaceutical Expenditure Forecast Model 98
Healthcare Expenditure Forecast Model 98
Notes On Methodology 99
Risk/Reward Index Methodology 100
Index Overview 101
Table: Pharmaceutical Risk/Reward Index Indicators 101
Indicator Weightings 102

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

  • $ 5 750
  • Industry report
  • April 2016
  • by Feedback Business Consulting

This report provides an insight into the Indian Pharmaceutical current market scenario, structure and practices. In depth market scenario includes; - Current market size estimates, including domestic market, ...

Empty Capsules Market by Product, Non-Gelatin, Application & End User - Global Forecast to 2021

Empty Capsules Market by Product, Non-Gelatin, Application & End User - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • May 2016
  • by MarketsandMarkets

The global empty capsules market is estimated to reach USD 2.13 billion by 2021, growing at a CAGR of 7.2% during the forecast period (2016–2021). The factors driving this market are rapidly increasing ...

Virus Filtration Market by Product, Application, Devices, Air, Water Purification, End User - Global Forecast to 2020

Virus Filtration Market by Product, Application, Devices, Air, Water Purification, End User - Global Forecast to 2020

  • $ 5 650
  • Industry report
  • April 2016
  • by MarketsandMarkets

The global virus filtration market is projected to reach USD 3.25 billion by 2020 from USD 1.82 billion in 2015, at a CAGR of 12.3% between 2015 and 2020. By product, the market includes kits and reagents, ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.